EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   4.6.1.18 | Acidosis |
10412952 |
Reversible nephrotoxicity of onconase and effect of lysine pH on renal onconase uptake. |
unassigned |
0 |
| 4.6.1.18 | Adenocarcinoma |
10810394 |
Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
2
4
1 |
| 4.6.1.18 | Adenocarcinoma |
11002220 |
Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 4.6.1.18 | Adenocarcinoma |
12626415 |
Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 4.6.1.18 | Adenocarcinoma |
19126965 |
Altered glycosylation in tumours focused to cancer diagnosis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
4
3
0 |
| 4.6.1.18 | Adenocarcinoma |
21594308 |
Tamoxifen in patients with advanced pancreatic adenocarcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
4
3
0 |
| 4.6.1.18 | Adenocarcinoma |
25533084 |
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
4
0 |
| 4.6.1.18 | Adenocarcinoma |
26405690 |
Human Cancer Antigen Globo H Is a Cell-Surface Ligand for Human Ribonuclease 1. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 4.6.1.18 | Adenocarcinoma |
28561015 |
Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
2
4
1 |
| 4.6.1.18 | Adenocarcinoma of Lung |
9735389 |
Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
3
1
0 |
